Hottendorf G H, Gordon L L
Antimicrob Agents Chemother. 1980 Jul;18(1):176-81. doi: 10.1128/AAC.18.1.176.
Most investigations of the comparative nephrotoxicities of aminoglycosides in animals have utilized large multiples of the human dose. Furthermore, many of these assessments have used only one or two dose levels and have not described a dose-response comparison among antibiotics. Because of this lack of comparative dose-response data over a range of low multiples of the human dose, the nephrotoxicities of gentamicin, tobramycin, and amikacin were investigated in 180 rats, utilizing doses ranging from one to seven times the equivalent human clinical doses. Histopathological evaluations of both kidneys from each rat were scored without knowledge of the treatment, and statistical analyses of the results indicated that a linear and parallel dose-response relationship existed for each drug, the relative nephrotoxicity over the range of doses analyzed was gentamicin > tobramycin > amikacin (P = 0.0001), and, unlike amikacin, the human dose equivalents (milligrams per kilogram) of gentamicin and tobramycin were significantly nephrotoxic in rats (P < 0.05).
大多数关于氨基糖苷类药物在动物体内相对肾毒性的研究都使用了数倍于人体剂量的药物。此外,这些评估中许多仅采用了一两个剂量水平,且未描述不同抗生素之间的剂量-反应比较。由于缺乏在数倍于人体低剂量范围内的比较剂量-反应数据,因此在180只大鼠中研究了庆大霉素、妥布霉素和阿米卡星的肾毒性,使用的剂量范围为等效人体临床剂量的1至7倍。在不知道治疗情况的前提下,对每只大鼠的双肾进行组织病理学评估并评分,结果的统计分析表明,每种药物都存在线性和平行的剂量-反应关系,在所分析的剂量范围内,相对肾毒性为庆大霉素>妥布霉素>阿米卡星(P = 0.0001),并且与阿米卡星不同,庆大霉素和妥布霉素的人体等效剂量(毫克/千克)在大鼠中具有显著肾毒性(P < 0.05)。